Navigation Links
American Association for Cancer Research hosts 102nd annual meeting in 2011
Date:11/17/2010

What: The AACR 102nd Annual Meeting 2011 will feature the latest findings in laboratory, translational, prevention, epidemiological and clinical cancer research. This year's Annual Meeting focuses on innovative research, novel technologies, lifesaving therapies in the pipeline, clinical trials and new approaches to cancer prevention.

To help you plan your coverage of the Annual Meeting, the program schedule and related scientific abstracts will be available online at www.aacr.org/page23084.aspx in early March. An electronic press kit containing the press releases and highlighted abstracts will be available to subscribing reporters one week prior to the meeting via EurekAlert and Newswise, and by request through the AACR Communications Department.

More than 6,000 abstracts will be presented at the meeting, complementing an outstanding program of scientific and educational events. The AACR 102nd Annual Meeting 2011 attracts world leaders in cancer research and treatment, including clinical oncologists, basic scientists, translational researchers and epidemiologists, who are working to improve prevention, diagnosis and patient care with the ultimate goal of eradicating cancer.

When: April 2-6, 2011

Where:

Orange County Convention Center
Orlando, Fla.

Press Registration and Hotel Accommodations:

The advanced registration deadline is Friday, March 11. The deadline for housing requests is Wednesday, Feb. 26. A limited number of rooms have been set aside for reporters; however, we cannot guarantee hotel availability after this date. Please visit the following link to download a registration and housing form: www.aacr.org/page23073.aspx


'/>"/>

Contact: Natalie Poole
natalie.poole@aacr.org
276-646-0619
American Association for Cancer Research
Source:Eurekalert

Page: 1

Related biology news :

1. Tips from the journals of the American Society for Microbiology
2. Cardium Reports on Presentation at American Heart Association Meeting Relating to Gene Delivery to the Heart and Generx Clinical Development
3. Einstein researcher receives American Cancer Society Medal of Honor
4. MARC travel awards announced for the 2010 American Society of Human Genetics annual meeting
5. Fink receives Gruber Genetics Prize, lectures at American Society of Human Genetics annual meeting
6. Rensselaer researcher wins prestigious American Cancer Society award for work on cancer
7. Consuming vegetables linked to decreased breast cancer risk in African-American women
8. American Chemical Society posts new online collection of resources on climate change
9. Proposed dietary guidelines for Americans sharply debated
10. American Migraine Foundation launches new podcast series
11. Wiecha receives grant to study face-to-face vs. virtual health education for African-American women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: